Increased glycolysis and cellular crosstalk in eosinophilic chronic rhinosinusitis with nasal polyps.

chronic rhinosinusitis epithelial mesenchymal interaction epithelium glycolysis single cell RNA sequencing

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 14 10 2023
accepted: 06 02 2024
medline: 6 3 2024
pubmed: 6 3 2024
entrez: 6 3 2024
Statut: epublish

Résumé

Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the sinonasal mucosa with distinct endotypes including type 2 (T2) high eosinophilic CRS with nasal polyps (eCRSwNP), T2 low non-eosinophilic CRS with nasal polyps (neCRSwNP), and CRS without nasal polyps (CRSsNP). Given the heterogeneity of disease, we hypothesized that assessment of single cell RNA sequencing (scRNA-seq) across this spectrum of disease would reveal connections between infiltrating and activated immune cells and the epithelial and stromal populations that reside in sinonasal tissue. Here we find increased expression of genes encoding glycolytic enzymes in epithelial cells (EpCs), stromal cells, and memory T-cell subsets from patients with eCRSwNP, as compared to healthy controls. In basal EpCs, this is associated with a program of cell motility and Rho GTPase effector expression. Across both stromal and immune subsets, glycolytic programming was associated with extracellular matrix interactions, proteoglycan generation, and collagen formation. Furthermore, we report increased cell-cell interactions between EpCs and stromal/immune cells in eCRSwNP compared to healthy control tissue, and we nominate candidate receptor-ligand pairs that may drive tissue remodeling. These findings support a role for glycolytic reprograming in T2-elicited tissue remodeling and implicate increased cellular crosstalk in eCRSwNP.

Identifiants

pubmed: 38444858
doi: 10.3389/fimmu.2024.1321560
pmc: PMC10912276
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1321560

Informations de copyright

Copyright © 2024 Huang, Mandanas, Djeddi, Fernandez-Salinas, Gutierrez-Arcelus and Barrett.

Déclaration de conflit d'intérêts

NB has served on scientific advisory boards for Regeneron. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.

Auteurs

George X Huang (GX)

Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, United States.
Department of Medicine, Harvard Medical School, Boston, MA, United States.

Michael V Mandanas (MV)

Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, United States.

Sarah Djeddi (S)

Division of Immunology, Boston Children's Hospital, Boston, MA, United States.
Department of Pediatrics, Harvard Medical School, Boston, MA, United States.
Broad Institute of MIT and Harvard, Cambridge, MA, United States.

Daniela Fernandez-Salinas (D)

Division of Immunology, Boston Children's Hospital, Boston, MA, United States.
Department of Pediatrics, Harvard Medical School, Boston, MA, United States.
Broad Institute of MIT and Harvard, Cambridge, MA, United States.

Maria Gutierrez-Arcelus (M)

Division of Immunology, Boston Children's Hospital, Boston, MA, United States.
Department of Pediatrics, Harvard Medical School, Boston, MA, United States.
Broad Institute of MIT and Harvard, Cambridge, MA, United States.

Nora A Barrett (NA)

Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, United States.
Department of Medicine, Harvard Medical School, Boston, MA, United States.

Classifications MeSH